PBE icon

Invesco Biotechnology & Genome ETF
PBE

Overview Fund Activity

74 hedge funds and large institutions have $93.2M invested in Invesco Biotechnology & Genome ETF in 2018 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 15 increasing their positions, 16 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
74
Holders Change
+1
Holders Change %
+1.37%
% of All Funds
1.69%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
14
Increased
15
Reduced
16
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
ACM
Arlington Capital Management
Illinois
$32.7M
2
UBS Group
UBS Group
Switzerland
$8.78M
3
YIA
YHB Investment Advisors
Connecticut
$1.27M
4
Wells Fargo
Wells Fargo
California
$5.76M
5
Morgan Stanley
Morgan Stanley
New York
$9.15M

Top Sellers

1
Citadel Advisors
Citadel Advisors
Florida
$0
2
Jane Street
Jane Street
New York
$0
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
$3.46M
4
CWM
Cornerstone Wealth Management
Missouri
$0
5
TAM
Trillium Asset Management
Massachusetts
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Jane Street
76
Jane Street
New York
– -$645K -11,791 Closed
TAM
77
Trillium Asset Management
Massachusetts
– -$215K -3,935 Closed
CIBC Private Wealth Group
78
CIBC Private Wealth Group
Georgia
– -$160K -2,925 Closed
Envestnet Asset Management
79
Envestnet Asset Management
Illinois
– -$155K -2,836 Closed
GT
80
Glenmede Trust
Pennsylvania
– -$86K -1,579 Closed
SEI Investments
81
SEI Investments
Pennsylvania
– -$51K -941 Closed
Manulife (Manufacturers Life Insurance)
82
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$33K -600 Closed
GFP
83
Gryphon Financial Partners
Ohio
– -$12K -217 Closed
CF
84
Centaurus Financial
California
– -$1K -17 Closed
1 2 3
4